ISSN 1662-4009 (online)

Previous issue | Volume 21 | ESPEYB21

Yearbook of Paediatric Endocrinology 2024

3. Thyroid

Defects in Thyroid Hormone Transport, Metabolism and Action

ey0021.3-10 | Defects in Thyroid Hormone Transport, Metabolism and Action | ESPEYB21

3.10. Resistance to thyroid hormone induced tachycardia in RTH[alpha] syndrome

Dore Riccardo , Watson Laura , Hollidge Stefanie , Krause Christin , Sentis Sarah Christine , Oelkrug Rebecca , Geiszler Cathleen , Johann Kornelia , Pedaran Mehdi , Lyons Greta , Lopez-Alcantara Nuria , Resch Julia , Sayk Friedhelm , Iwen Karl Alexander , Franke Andre , Boysen Teide Jens , Dalley Jeffrey W , Lorenz Kristina , Moran Carla , Rennie Kirsten L , Arner Anders , Kirchner Henriette , Chatterjee Krishna , Mittag Jens

Brief Summary: This study examined resistance to thyroid hormone (TH)-induced tachycardia in patients with Resistance to THα (RTHα). This rare condition is caused by mutations in the TH receptor alpha (TRα1), and leads to hypothyroidism in TRα1-expressing tissues, including the heart. While high doses of thyroxine (T4) are typically used to treat this condition, patients with RTHα do not exhibit the expected increase in heart rate despite overcoming ti...

ey0021.3-11 | Defects in Thyroid Hormone Transport, Metabolism and Action | ESPEYB21

3.11. Identification of human TRIAC transmembrane transporters

Becker Paul Carlos , Guth-Steffens Mandy , Lazarow Katina , Sonntag Niklas , Braun Doreen , Masfaka Islam , Renko Kostja , Schomburg Lutz , Kohrle Josef , von Kries Jens Peter , Schweizer Ulrich , Krause Gerd , Protze Jonas

Brief Summary: This basic science study examined how 3,5,3’-triiodothyroacetic acid (TRIAC) - a thyroid hormone (TH) receptor agonist used in patients with resistance to TH, and in patients with Allan-Herndon-Dudley syndrome (AHDS), caused by mutations in monocarboxylate transporter 8 (MCT8) - is transported into cells independent of MCT8. Through a genome-wide RNAi screening in HepG2 cells, two key transporters, SLC22A9 (OAT7) and SLC29A2 (ENT2), were identified that fac...